Genaxis
Overview
Genaxis is a South Korean accelerator and venture capital firm that invests in early-stage startups in deep tech fields, with a focus on bio and healthcare, big data, artificial intelligence, and medical services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MThera Pharma | Aug 2022 | Series B | Co-investor |
| InHandPlus | Jul 2023 | Series A | Co-investor |
| Celliaz Co., Ltd. | Sep 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genaxis based?
Genaxis is headquartered in Seoul, South Korea.
When was Genaxis founded?
Genaxis was founded in 2018.
How many portfolio companies does Genaxis have?
Genaxis has 3 portfolio companies in Caplight's dataset.
What are some companies in Genaxis's portfolio?
Portfolio companies visible on Caplight include MThera Pharma, InHandPlus, Celliaz Co., Ltd..
What was Genaxis's most recent investment shown here?
Genaxis's most recent investment in this portfolio sample was in InHandPlus in 2023.
What sectors does Genaxis focus on?
Genaxis focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Genaxis focus on?
Genaxis typically invests at the Early stage.
What is Genaxis's AUM?
Genaxis's assets under management are estimated at over $6.0M.